GlassScriptPhysician profile
Susan D Sweat
NPI 1447200084
$20,294.60
in general payments reported to CMS, 2019-2025
32 companies · $3,579 in 2025
The $3,579 reported for 2025 was more than what 88% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,355 · 2020: $191 · 2021: $1,621 · 2022: $2,180 · 2023: $2,589 · 2024: $779 · 2025: $3,579.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,494 · Food and Beverage: $3,255 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,493.71 |
| Food and Beverage | $3,254.79 |
| Education | $198.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,742.57 | 2019-2024 | |
| Teleflex LLC | $4,428.03 | 2021-2025 | Urolift, Barrigel |
| Procept Biorobotics Corporation | $3,705.02 | 2022-2025 | Aquabeam Robotic System, Aquabeam System |
| Astellas Pharma US INC | $313.71 | 2019-2024 | |
| Janssen Biotech, INC. | $280.58 | 2019-2022 | |
| Pfizer INC. | $246.91 | 2019-2025 | |
| Olympus America INC. | $146.46 | 2022-2025 | Itind System |
| Boston Scientific Corporation | $132.37 | 2022-2023 | Lithovue |
| Sumitomo Pharma America, INC. | $124.96 | 2023 | Gemtesa |
| Coloplast Corp | $110.85 | 2021-2025 | |
| Abbvie INC. | $107.03 | 2021-2024 | Lupron Depot |
| Swan Valley Medical Incorporated | $105.24 | 2022 | |
| Allergan, INC. | $87.71 | 2019-2022 | |
| Conmed Corporation | $83.33 | 2022 | |
| Photocure INC | $70.45 | 2019 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rochester Medical Corporation | $67.14 | 2019-2020 | |
| Convatec INC. | $64.17 | 2021-2024 | |
| Antares Pharma, INC. | $63.78 | 2021 | |
| Tela Bio, INC. | $55.55 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $52.49 | 2019 | |
| Immunitybio, INC. | $48.95 | 2025 | |
| Axonics, INC. | $47.15 | 2021-2022 | |
| Karl Storz Endoscopy-America | $36.24 | 2019-2020 | |
| Urovant Sciences INC | $31.50 | 2022 | |
| Mission Pharmacal Company | $27.17 | 2019 | |
| Progenics Pharmaceuticals, INC. | $23.02 | 2023 | Pylarify |
| Smith+Nephew, INC. | $19.25 | 2019 | |
| Calyxo, INC. | $18.44 | 2024 | Cvac Aspiration System |
| Urogen Pharma, INC. | $15.14 | 2024 | |
| Alnylam Pharmaceuticals INC. | $14.37 | 2020 | |
| Kerecis Limited | $14.10 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Osiris Therapeutics INC. | $10.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Sweat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.